Tg Therapeutics TGTX
NASDAQ TGTX
$53.20 -1.33 (-2.44%)
At close: Oct 21, 2026 · 4:00 PM EDT

Tg Therapeutics (TGTX) Receivables - Other (2010)

Updated

Tg Therapeutics (TGTX) recorded Receivables - Other of $244,479 in Q4 2010.

Analysis

Tg Therapeutics (TGTX) Receivables - Other (2010) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn
10 Tg Therapeutics 7.56 Bn 6.94 Bn 199.14 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2010 244,479.00
API Access

Tg Therapeutics Receivables - Other API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=receivables-other&ticker=TGTX&period=max&api_key=YOUR_API_KEY